VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
1098
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
198
Interactions with Platform & by Email
PARTICIPANTS
44
Unique # Participated
VALIDATIONS
21
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JUL 2020
TABLES
216
PAGES
292
EDITION
8
PRICE
USD $5450
It Pays to Understand the Dynamics of Competition in Your Business Ecosystem.
Who Are Your Competitors in the Influenza Medication Market?
Amid the COVID-19 crisis, the global market for Influenza Medication estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 0.4% over the analysis period 2020-2027.Zanamivir, one of the segments analyzed in the report, is projected to grow at a -0.4% CAGR to reach US$97.5 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oseltamivir segment is readjusted to a revised 0.8% CAGR for the next 7-year period. This segment currently accounts for a 49.5% share of the global Influenza Medication market.
The Influenza Medication market in the U.S. is estimated at US$458.7 Million in the year 2020. The country currently accounts for a 27.17% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$311.8 Million in the year 2027 trailing a CAGR of 1.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -0.5% and 0.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately -0.2% CAGR while Rest of European market (as defined in the study) will reach US$311.8 Million by the year 2027.
In the global Peramivir segment, USA, Canada, Japan, China and Europe will drive the 0.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$177.4 Million in the year 2020 will reach a projected size of US$178.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$220.9 Million by the year 2027, while Latin America will expand at a 0.9% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 292-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Daiichi Sankyo Co., Ltd.; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Mylan, Inc.; Natco Pharma Limited; Sandoz International GmbH; Sun Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.
» Distribution Channel (Hospitals, Clinics, Pharmacies) » Product (Zanamivir, Oseltamivir, Peramivir, Amantadine, Rimantadine, Other Products)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Influenza Medication Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Influenza Medication Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Influenza Medication Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 |
| Influenza Medication Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Zanamivir (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Zanamivir (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Zanamivir (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Oseltamivir (Product) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Oseltamivir (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Oseltamivir (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Peramivir (Product) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 |
| Peramivir (Product) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017 |
| Peramivir (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Amantadine (Product) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 |
| Amantadine (Product) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017 |
| Amantadine (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Rimantadine (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Rimantadine (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Rimantadine (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Other Products (Product) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025 |
| Other Products (Product) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017 |
| Other Products (Product) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 |
| Hospitals (Distribution Channel) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025 |
| Hospitals (Distribution Channel) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017 |
| Hospitals (Distribution Channel) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Clinics (Distribution Channel) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Clinics (Distribution Channel) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Clinics (Distribution Channel) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Pharmacies (Distribution Channel) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Pharmacies (Distribution Channel) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Pharmacies (Distribution Channel) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Influenza Medication Market Share (in %) by Company: 2019 & 2025 |
| United States Influenza Medication Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 |
| Influenza Medication Market in the United States by Product: A Historic Review in US$ Thousand for 2009-2017 |
| United States Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| United States Influenza Medication Market Estimates and Projections in US$ Thousand by Distribution Channel: 2018 to 2025 |
| Influenza Medication Market in the United States by Distribution Channel: A Historic Review in US$ Thousand for 2009-2017 |
| United States Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Influenza Medication Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 |
| Canadian Influenza Medication Historic Market Review by Product in US$ Thousand: 2009-2017 |
| Influenza Medication Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| Canadian Influenza Medication Market Estimates and Forecasts in US$ Thousand by Distribution Channel: 2018 to 2025 |
| Canadian Influenza Medication Historic Market Review by Distribution Channel in US$ Thousand: 2009-2017 |
| Influenza Medication Market in Canada: Percentage Share Breakdown of Sales by Distribution Channel for 2009, 2019, and 2025 |
| JAPAN |
| Japanese Market for Influenza Medication: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 |
| Influenza Medication Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 |
| Japanese Influenza Medication Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Japanese Market for Influenza Medication: Annual Sales Estimates and Projections in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Influenza Medication Market in Japan: Historic Sales Analysis in US$ Thousand by Distribution Channel for the Period 2009-2017 |
| Japanese Influenza Medication Market Share Analysis by Distribution Channel: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Influenza Medication Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 |
| Influenza Medication Historic Market Analysis in China in US$ Thousand by Product: 2009-2017 |
| Chinese Influenza Medication Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Influenza Medication Market Growth Prospects in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Influenza Medication Historic Market Analysis in China in US$ Thousand by Distribution Channel: 2009-2017 |
| Chinese Influenza Medication Market by Distribution Channel: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| EUROPE |
| Market Facts & Figures |
| European Influenza Medication Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Influenza Medication Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| Influenza Medication Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 |
| European Influenza Medication Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Influenza Medication Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 |
| Influenza Medication Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017 |
| European Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| European Influenza Medication Market Estimates and Forecasts in US$ Thousand by Distribution Channel: 2018-2025 |
| Influenza Medication Market in Europe in US$ Thousand by Distribution Channel: A Historic Review for the Period 2009-2017 |
| European Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| FRANCE |
| Influenza Medication Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Influenza Medication Historic Market Scenario in US$ Thousand by Product: 2009-2017 |
| French Influenza Medication Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in France by Distribution Channel: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Influenza Medication Historic Market Scenario in US$ Thousand by Distribution Channel: 2009-2017 |
| French Influenza Medication Market Share Analysis by Distribution Channel: 2009 VS 2019 VS 2025 |
| GERMANY |
| Influenza Medication Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 |
| German Influenza Medication Historic Market Analysis in US$ Thousand by Product: 2009-2017 |
| German Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| German Influenza Medication Historic Market Analysis in US$ Thousand by Distribution Channel: 2009-2017 |
| German Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Influenza Medication Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 |
| Influenza Medication Historic Market Analysis in Italy in US$ Thousand by Product: 2009-2017 |
| Italian Influenza Medication Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Influenza Medication Market Growth Prospects in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Influenza Medication Historic Market Analysis in Italy in US$ Thousand by Distribution Channel: 2009-2017 |
| Italian Influenza Medication Market by Distribution Channel: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED KINGDOM |
| United Kingdom Market for Influenza Medication: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 |
| Influenza Medication Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 |
| United Kingdom Influenza Medication Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Influenza Medication: Annual Sales Estimates and Projections in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Influenza Medication Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Distribution Channel for the Period 2009-2017 |
| United Kingdom Influenza Medication Market Share Analysis by Distribution Channel: 2009 VS 2019 VS 2025 |
| SPAIN |
| Spanish Influenza Medication Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 |
| Spanish Influenza Medication Historic Market Review by Product in US$ Thousand: 2009-2017 |
| Influenza Medication Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| Spanish Influenza Medication Market Estimates and Forecasts in US$ Thousand by Distribution Channel: 2018 to 2025 |
| Spanish Influenza Medication Historic Market Review by Distribution Channel in US$ Thousand: 2009-2017 |
| Influenza Medication Market in Spain: Percentage Share Breakdown of Sales by Distribution Channel for 2009, 2019, and 2025 |
| RUSSIA |
| Russian Influenza Medication Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 |
| Influenza Medication Market in Russia by Product: A Historic Review in US$ Thousand for 2009-2017 |
| Russian Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Russian Influenza Medication Market Estimates and Projections in US$ Thousand by Distribution Channel: 2018 to 2025 |
| Influenza Medication Market in Russia by Distribution Channel: A Historic Review in US$ Thousand for 2009-2017 |
| Russian Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Influenza Medication Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 |
| Influenza Medication Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017 |
| Rest of Europe Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Rest of Europe Influenza Medication Market Estimates and Forecasts in US$ Thousand by Distribution Channel: 2018-2025 |
| Influenza Medication Market in Rest of Europe in US$ Thousand by Distribution Channel: A Historic Review for the Period 2009-2017 |
| Rest of Europe Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Asia-Pacific Influenza Medication Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Influenza Medication Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017 |
| Asia-Pacific Influenza Medication Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Influenza Medication Historic Market Scenario in US$ Thousand by Product: 2009-2017 |
| Asia-Pacific Influenza Medication Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in Asia-Pacific by Distribution Channel: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Influenza Medication Historic Market Scenario in US$ Thousand by Distribution Channel: 2009-2017 |
| Asia-Pacific Influenza Medication Market Share Analysis by Distribution Channel: 2009 VS 2019 VS 2025 |
| AUSTRALIA |
| Influenza Medication Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 |
| Australian Influenza Medication Historic Market Analysis in US$ Thousand by Product: 2009-2017 |
| Australian Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Australian Influenza Medication Historic Market Analysis in US$ Thousand by Distribution Channel: 2009-2017 |
| Australian Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| INDIA |
| Indian Influenza Medication Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 |
| Indian Influenza Medication Historic Market Review by Product in US$ Thousand: 2009-2017 |
| Influenza Medication Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| Indian Influenza Medication Market Estimates and Forecasts in US$ Thousand by Distribution Channel: 2018 to 2025 |
| Indian Influenza Medication Historic Market Review by Distribution Channel in US$ Thousand: 2009-2017 |
| Influenza Medication Market in India: Percentage Share Breakdown of Sales by Distribution Channel for 2009, 2019, and 2025 |
| SOUTH KOREA |
| Influenza Medication Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 |
| South Korean Influenza Medication Historic Market Analysis in US$ Thousand by Product: 2009-2017 |
| Influenza Medication Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| South Korean Influenza Medication Historic Market Analysis in US$ Thousand by Distribution Channel: 2009-2017 |
| Influenza Medication Market Share Distribution in South Korea by Distribution Channel: 2009 VS 2019 VS 2025 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Market for Influenza Medication: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 |
| Influenza Medication Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 |
| Rest of Asia-Pacific Influenza Medication Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Market for Influenza Medication: Annual Sales Estimates and Projections in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Influenza Medication Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Distribution Channel for the Period 2009-2017 |
| Rest of Asia-Pacific Influenza Medication Market Share Analysis by Distribution Channel: 2009 VS 2019 VS 2025 |
| LATIN AMERICA |
| Latin American Influenza Medication Market Trends by Region/Country in US$ Thousand: 2018-2025 |
| Influenza Medication Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Influenza Medication Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Latin American Influenza Medication Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 |
| Influenza Medication Historic Market Analysis in Latin America in US$ Thousand by Product: 2009-2017 |
| Latin American Influenza Medication Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Latin American Influenza Medication Market Growth Prospects in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Influenza Medication Historic Market Analysis in Latin America in US$ Thousand by Distribution Channel: 2009-2017 |
| Latin American Influenza Medication Market by Distribution Channel: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| ARGENTINA |
| Argentinean Influenza Medication Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 |
| Influenza Medication Market in Argentina in US$ Thousand by Product: A Historic Review for the Period 2009-2017 |
| Argentinean Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Argentinean Influenza Medication Market Estimates and Forecasts in US$ Thousand by Distribution Channel: 2018-2025 |
| Influenza Medication Market in Argentina in US$ Thousand by Distribution Channel: A Historic Review for the Period 2009-2017 |
| Argentinean Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| BRAZIL |
| Influenza Medication Market in Brazil by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Brazilian Influenza Medication Historic Market Scenario in US$ Thousand by Product: 2009-2017 |
| Brazilian Influenza Medication Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in Brazil by Distribution Channel: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Brazilian Influenza Medication Historic Market Scenario in US$ Thousand by Distribution Channel: 2009-2017 |
| Brazilian Influenza Medication Market Share Analysis by Distribution Channel: 2009 VS 2019 VS 2025 |
| MEXICO |
| Influenza Medication Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 |
| Mexican Influenza Medication Historic Market Analysis in US$ Thousand by Product: 2009-2017 |
| Mexican Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Mexican Influenza Medication Historic Market Analysis in US$ Thousand by Distribution Channel: 2009-2017 |
| Mexican Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| REST OF LATIN AMERICA |
| Rest of Latin America Influenza Medication Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 |
| Influenza Medication Market in Rest of Latin America by Product: A Historic Review in US$ Thousand for 2009-2017 |
| Rest of Latin America Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Rest of Latin America Influenza Medication Market Estimates and Projections in US$ Thousand by Distribution Channel: 2018 to 2025 |
| Influenza Medication Market in Rest of Latin America by Distribution Channel: A Historic Review in US$ Thousand for 2009-2017 |
| Rest of Latin America Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| MIDDLE EAST |
| The Middle East Influenza Medication Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Influenza Medication Market in the Middle East by Region/Country in US$ Thousand: 2009-2017 |
| The Middle East Influenza Medication Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Influenza Medication Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 |
| The Middle East Influenza Medication Historic Market by Product in US$ Thousand: 2009-2017 |
| Influenza Medication Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| The Middle East Influenza Medication Market Estimates and Forecasts in US$ Thousand by Distribution Channel: 2018 to 2025 |
| The Middle East Influenza Medication Historic Market by Distribution Channel in US$ Thousand: 2009-2017 |
| Influenza Medication Market in the Middle East: Percentage Share Breakdown of Sales by Distribution Channel for 2009, 2019, and 2025 |
| IRAN |
| Iranian Market for Influenza Medication: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 |
| Influenza Medication Market in Iran: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 |
| Iranian Influenza Medication Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Iranian Market for Influenza Medication: Annual Sales Estimates and Projections in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Influenza Medication Market in Iran: Historic Sales Analysis in US$ Thousand by Distribution Channel for the Period 2009-2017 |
| Iranian Influenza Medication Market Share Analysis by Distribution Channel: 2009 VS 2019 VS 2025 |
| ISRAEL |
| Israeli Influenza Medication Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 |
| Influenza Medication Market in Israel in US$ Thousand by Product: A Historic Review for the Period 2009-2017 |
| Israeli Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Israeli Influenza Medication Market Estimates and Forecasts in US$ Thousand by Distribution Channel: 2018-2025 |
| Influenza Medication Market in Israel in US$ Thousand by Distribution Channel: A Historic Review for the Period 2009-2017 |
| Israeli Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| SAUDI ARABIA |
| Saudi Arabian Influenza Medication Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 |
| Influenza Medication Historic Market Analysis in Saudi Arabia in US$ Thousand by Product: 2009-2017 |
| Saudi Arabian Influenza Medication Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Saudi Arabian Influenza Medication Market Growth Prospects in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Influenza Medication Historic Market Analysis in Saudi Arabia in US$ Thousand by Distribution Channel: 2009-2017 |
| Saudi Arabian Influenza Medication Market by Distribution Channel: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED ARAB EMIRATES |
| Influenza Medication Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 |
| United Arab Emirates Influenza Medication Historic Market Analysis in US$ Thousand by Product: 2009-2017 |
| Influenza Medication Market Share Distribution in United Arab Emirates by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| United Arab Emirates Influenza Medication Historic Market Analysis in US$ Thousand by Distribution Channel: 2009-2017 |
| Influenza Medication Market Share Distribution in United Arab Emirates by Distribution Channel: 2009 VS 2019 VS 2025 |
| REST OF MIDDLE EAST |
| Influenza Medication Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 |
| Rest of Middle East Influenza Medication Historic Market Analysis in US$ Thousand by Product: 2009-2017 |
| Rest of Middle East Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Influenza Medication Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Distribution Channel for the Period 2018-2025 |
| Rest of Middle East Influenza Medication Historic Market Analysis in US$ Thousand by Distribution Channel: 2009-2017 |
| Rest of Middle East Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| AFRICA |
| African Influenza Medication Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 |
| Influenza Medication Market in Africa by Product: A Historic Review in US$ Thousand for 2009-2017 |
| African Influenza Medication Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| African Influenza Medication Market Estimates and Projections in US$ Thousand by Distribution Channel: 2018 to 2025 |
| Influenza Medication Market in Africa by Distribution Channel: A Historic Review in US$ Thousand for 2009-2017 |
| African Influenza Medication Market Share Breakdown by Distribution Channel: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 46 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com